Clinical characteristics of the population in this study
| Study population (n=87) | |
| Age | 51.8±14.9 |
| Sex, male | 40 (46.0%) |
| HTN | 50 (57.5%) |
| DM | 23 (26.4%) |
| Smoking | 21 (24.1%) |
| Family history | 12 (13.8%) |
| Presenting symptoms | |
| Hemiparesis | 47 (54.0%) |
| Dysarthria | 3 (3.5%) |
| Cortical symptoms | 23 (26.4%) |
| Visual symptoms | 2 (2.3%) |
| Ataxia | 1 (1.2%) |
| Dizziness | 1 (1.2%) |
| Others | 10 (11.5%) |
| Clinical course during hospitalisation | |
| Stroke | 2 (2.3%) |
| TIA | 4 (4.6%) |
| Admission NIHSS | 2 (0, 5) |
| Admission mRS | 1 (0, 4.0) |
| Follow-up after discharge | |
| Total follow-up period (year, IQR) | 5.2 (3.1–9.2) |
| At 6 month mRS (IQR) | 1 (0–2) |
| Recurrence of stroke | 3/87 (3.4%) |
| Deterioration on CTP | 3/71 (4.2%) |
CTP, CT perfusion; DM, diabetes mellitus; HTN, hypertension; mRS, modified Rankin scale; NIHSS, National Institute of Health Stroke Scale; TIA, transient ischaemic attack.